A 32-year-old woman with a 5-year history of SLE presents with new-onset photosensitive rash, arthralgia, and positive ANA. All of the following are mechanisms of tissue injury in SLE EXCEPT:

Question

Accepted Answer

C. Type IV hypersensitivity reaction with CD8+ T-cell infiltration as the primary pathogenic mechanism. ## Pathogenic Mechanisms in SLE

**Key Point:** SLE is primarily a **Type III (immune complex)** and **Type II (antibody-mediated)** hypersensitivity disease. Type IV hypersensitivity (cell-mediated, CD8+ T-cell driven) is NOT a primary mechanism in SLE; it is characteristic of delayed-type hypersensitivity diseases like tuberculosis, contact dermatitis, and type 1 diabetes.

### Classification of SLE Tissue Injury Mechanisms

| Mechanism | Hypersensitivity Type | Role in SLE | Evidence |
|---|---|---|---|
| Immune complex deposition | Type III | Primary | IC found in kidneys, skin, joints; complement activation (↓C3, C4) |
| Antibody-mediated cytotoxicity | Type II | Major | Anti-RBC, anti-platelet, anti-neutrophil antibodies cause hemolysis, thrombocytopenia |
| T-cell infiltration (CD8+) | Type IV | **Minimal** | Not the primary driver; T cells are secondary to IC and antibody pathology |
| Neutrophil extracellular traps (NETs) | Innate inflammation | Emerging | NET-derived autoantigens (dsDNA, histones) perpetuate autoimmunity |

**High-Yield:** SLE is **NOT** a Type IV hypersensitivity disease. Type IV hypersensitivity is seen in:
- Tuberculosis
- Contact dermatitis
- Type 1 diabetes mellitus
- Hashimoto thyroiditis (T-cell infiltration)
- Delayed-type drug reactions

### Correct Mechanisms in SLE

#### 1. Immune Complex Deposition (Type III Hypersensitivity)

```mermaid
flowchart TD
  A[Autoantigen + Autoantibody]:::outcome --> B[Immune Complex Formation]:::outcome
  B --> C[Deposition in Kidney, Skin, Joints]:::outcome
  C --> D[Complement Activation via Classical Pathway]:::action
  D --> E[C3a, C5a Generation]:::outcome
  E --> F[Neutrophil Infiltration & Inflammation]:::action
  F --> G[Tissue Damage: Glomerulonephritis, Vasculitis]:::urgent
```

**Clinical Pearl:** Lupus nephritis (Class III–IV) is the hallmark of IC-mediated injury; low serum C3 and C4 reflect complement consumption and correlate with disease activity.

#### 2. Antibody-Mediated Cytotoxicity (Type II Hypersensitivity)

- **Anti-RBC antibodies** → hemolytic anemia
- **Anti-platelet antibodies** → thrombocytopenia
- **Anti-neutrophil antibodies** → neutropenia
- **Anti-phospholipid antibodies** → thrombosis, recurrent miscarriage

#### 3. Neutrophil Extracellular Traps (NETs) — Emerging Mechanism

**Key Point:** Defective clearance of apoptotic cells and NETs allows release of nuclear autoantigens (dsDNA, histones, nucleosomes), which drive further autoimmunity and perpetuate the disease cycle.

**Clinical Pearl:** Impaired clearance of apoptotic material is a hallmark of SLE pathogenesis; defects in C1q, C3, and C4 (which normally opsonize apoptotic cells) predispose to SLE.

**Warning:** Do NOT confuse SLE with Type IV hypersensitivity diseases — while T cells are present in SLE lesions, they are **secondary** to IC and antibody-mediated injury, not the primary driver.

Answer

A. Direct antibody-mediated cytotoxicity against cell surface antigens (e.g., anti-RBCM, anti-platelet)

Answer

B. Immune complex deposition in glomeruli and blood vessel walls triggering complement activation

Answer

D. Neutrophil extracellular traps (NETs) releasing autoantigens and perpetuating autoimmunity

A 32-year-old woman with a 5-year history of SLE presents with new-onset photosensitive rash, arthralgia, and positive ANA. All of the following are mechanisms of tissue injury in SLE EXCEPT:

Explanation

Pathogenic Mechanisms in SLE

Classification of SLE Tissue Injury Mechanisms

Correct Mechanisms in SLE

1. Immune Complex Deposition (Type III Hypersensitivity)

2. Antibody-Mediated Cytotoxicity (Type II Hypersensitivity)

3. Neutrophil Extracellular Traps (NETs) — Emerging Mechanism

Practice similar questions

Join our NEET PG community

Mechanism	Hypersensitivity Type	Role in SLE	Evidence
Immune complex deposition	Type III	Primary	IC found in kidneys, skin, joints; complement activation (↓C3, C4)
Antibody-mediated cytotoxicity	Type II	Major	Anti-RBC, anti-platelet, anti-neutrophil antibodies cause hemolysis, thrombocytopenia
T-cell infiltration (CD8+)	Type IV	Minimal	Not the primary driver; T cells are secondary to IC and antibody pathology
Neutrophil extracellular traps (NETs)	Innate inflammation	Emerging	NET-derived autoantigens (dsDNA, histones) perpetuate autoimmunity